An appreciation of the roles of ChREBP and SHP in regulating Mttp and VLDL secretion will be beneficial for understanding the role of nutritional signals in the development of NAFLD and dyslipidemia. This evidence concerns the gene MT-TP and metabolic dysfunction-associated steatotic liver disease.